AccurKardia, an innovator in ECG-based diagnostics technology, has announced that its Aortic Valve Stenosis (AVS) ECG-based ...

Because this pain could also be a sign of cardiovascular issues, the physician recommended an electrocardiogram ... Go with the flow One such cardiology practice that took on the mantra of ...

Through a recent communication directed to the Directors/Principals/Deans of all medical colleges/institutes under the ...

The topics include electrocardiograms (ECG) interpretation and common abnormalities in cardiology ... And what disease process is it associated with versus a Bradyarrhythmia? Then I do a quiz at the ...

Traditional ECG interpretation methods can be prone to errors and inefficiencies ... The team propose that more public data is needed to bring neural networks into medical practice, which can help in ...

As a PGY-2 and PGY-3 you also learn how to take ambulatory call for your practice. In this rotation ... you may spend variable amounts of time on electrocardiogram (ECG) interpretation, ...

5 Outcomes for both groups of patients are poor, and investigation and management are inconsistent in practice.6 It is likely that this is at least in part due to variability in interpretation ...

The data collected will be sufficient to enable calculation of the T-MACS decision aid outcome, including the treating paramedic’s interpretation of the patient’s 12-lead ECG. However ... if T-MACS ...

A new continuous glucose monitor (CGM) that is not only non-invasive but that predicts blood sugar levels from ECG data ...

AccurKardia received FDA breakthrough device designation for its aortic valve stenosis (AVS) ECG-based AI screening software.

Patients with AAV who have ECG abnormalities may be at greater risk for cardiovascular and all-cause mortality.